Does LENVATINIB Cause Interstitial lung disease? 653 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 653 reports of Interstitial lung disease have been filed in association with LENVATINIB (Lenvima). This represents 1.9% of all adverse event reports for LENVATINIB.
653
Reports of Interstitial lung disease with LENVATINIB
1.9%
of all LENVATINIB reports
86
Deaths
313
Hospitalizations
How Dangerous Is Interstitial lung disease From LENVATINIB?
Of the 653 reports, 86 (13.2%) resulted in death, 313 (47.9%) required hospitalization, and 36 (5.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENVATINIB. However, 653 reports have been filed with the FAERS database.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LENVATINIB Alternatives Have Lower Interstitial lung disease Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE